285 related articles for article (PubMed ID: 33753119)
1. YAP1/TEAD1 upregulate platelet-derived growth factor receptor beta to promote vascular smooth muscle cell proliferation and neointima formation.
Osman I; Dong K; Kang X; Yu L; Xu F; Ahmed ASI; He X; Shen J; Hu G; Zhang W; Zhou J
J Mol Cell Cardiol; 2021 Jul; 156():20-32. PubMed ID: 33753119
[TBL] [Abstract][Full Text] [Related]
2. TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake.
Osman I; He X; Liu J; Dong K; Wen T; Zhang F; Yu L; Hu G; Xin H; Zhang W; Zhou J
Circ Res; 2019 Apr; 124(9):1309-1322. PubMed ID: 30801233
[TBL] [Abstract][Full Text] [Related]
3. P4HA2-induced prolyl hydroxylation of YAP1 restricts vascular smooth muscle cell proliferation and neointima formation.
Wang L; Liu T; Zheng Y; Zhou J; Hua H; Kong L; Huang W; Peng X; Wen T
Life Sci; 2023 Oct; 330():122002. PubMed ID: 37549826
[TBL] [Abstract][Full Text] [Related]
4. NF2 deficiency accelerates neointima hyperplasia following vascular injury via promoting YAP-TEAD1 interaction in vascular smooth muscle cells.
Sun X; Li S; Gan X; Chen K; Yang D; Yang Y
Aging (Albany NY); 2020 May; 12(10):9726-9744. PubMed ID: 32422606
[TBL] [Abstract][Full Text] [Related]
5. RhoGDI3 at the trans-Golgi network participates in NLRP3 inflammasome activation, VSMC phenotypic modulation, and neointima formation.
Sun J; Zhu Q; Yu X; Liang X; Guan H; Zhao H; Yao W
Atherosclerosis; 2023 Dec; 387():117391. PubMed ID: 38029612
[TBL] [Abstract][Full Text] [Related]
6. Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis.
Zhang Y; Wang Y; Zhang L; Xia L; Zheng M; Zeng Z; Liu Y; Yarovinsky T; Ostriker AC; Fan X; Weng K; Su M; Huang P; Martin KA; Hwa J; Tang WH
Circ Res; 2020 Sep; 127(7):855-873. PubMed ID: 32597702
[TBL] [Abstract][Full Text] [Related]
7. Dickkopf-1 promotes Vascular Smooth Muscle Cell proliferation and migration through upregulating UHRF1 during Cyclic Stretch application.
Zheng TF; Liu XL; Li X; Wang QQ; Zhao YC; Li X; Li MM; Zhang Y; Zhang M; Zhang WC; Zhang C; Zhang Y; Zhang M
Int J Biol Sci; 2021; 17(5):1234-1249. PubMed ID: 33867842
[TBL] [Abstract][Full Text] [Related]
8. Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin.
Xie C; Guo Y; Zhu T; Zhang J; Ma PX; Chen YE
J Biol Chem; 2012 Apr; 287(18):14598-605. PubMed ID: 22411986
[TBL] [Abstract][Full Text] [Related]
9. Serum and glucocorticoid-regulated kinase 1 promotes vascular smooth muscle cell proliferation via regulation of β-catenin dynamics.
Zhong W; Oguljahan B; Xiao Y; Nelson J; Hernandez L; Garcia-Barrio M; Francis SC
Cell Signal; 2014 Dec; 26(12):2765-72. PubMed ID: 25152363
[TBL] [Abstract][Full Text] [Related]
10. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
[TBL] [Abstract][Full Text] [Related]
11. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
12. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
[TBL] [Abstract][Full Text] [Related]
14. Role of polypyrimidine tract-binding protein 1/yin yang 2 signaling in regulating vascular smooth muscle cell proliferation and neointima hyperplasia.
Wang Z; Gan X; Qiu C; Yang D; Sun X; Zeng Z
Toxicol Appl Pharmacol; 2019 Nov; 383():114747. PubMed ID: 31499192
[TBL] [Abstract][Full Text] [Related]
15. Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation.
Huang L; Zhang SM; Zhang P; Zhang XJ; Zhu LH; Chen K; Gao L; Zhang Y; Kong XJ; Tian S; Zhang XD; Li H
J Am Heart Assoc; 2014 Oct; 3(5):e001309. PubMed ID: 25304854
[TBL] [Abstract][Full Text] [Related]
16. IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury.
Kohno T; Urao N; Ashino T; Sudhahar V; Inomata H; Yamaoka-Tojo M; McKinney RD; Fukai T; Ushio-Fukai M
Am J Physiol Cell Physiol; 2013 Sep; 305(6):C591-600. PubMed ID: 23657573
[TBL] [Abstract][Full Text] [Related]
17. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
[TBL] [Abstract][Full Text] [Related]
18. Apatinib attenuates phenotypic switching of arterial smooth muscle cells in vascular remodelling by targeting the PDGF Receptor-β.
Shao W; Li X; Peng J; Fan S; Liang M; Huang K
J Cell Mol Med; 2020 Sep; 24(17):10128-10139. PubMed ID: 32697395
[TBL] [Abstract][Full Text] [Related]
19. Gastrodin inhibits cell proliferation in vascular smooth muscle cells and attenuates neointima formation in vivo.
Zhu L; Guan H; Cui C; Tian S; Yang D; Wang X; Zhang S; Wang L; Jiang H
Int J Mol Med; 2012 Nov; 30(5):1034-40. PubMed ID: 22922870
[TBL] [Abstract][Full Text] [Related]
20. AKAP1 alleviates VSMC phenotypic modulation and neointima formation by inhibiting Drp1-dependent mitochondrial fission.
Sun J; Shao Y; Pei L; Zhu Q; Yu X; Yao W
Biomed Pharmacother; 2024 Jul; 176():116858. PubMed ID: 38850669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
